Select Medical Holdings

Healthcare · Medical Care Facilities

16.60$ -0.1% vs. previous close Closing price · As of: Jul 2, 2026

Statements

Income Statement

Select Medical Holdings (SEM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 1,421 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SEM
Line item	Q2 16	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	LTM
Revenue	1,098	1,054	1,046	1,111	1,121	1,097	1,114	1,253	1,296	1,267	1,265	1,325	1,361	1,393	1,375	1,415	1,233	1,424	1,460	1,546	1,564	1,534	1,560	1,600	1,585	1,568	1,581	1,665	1,675	1,666	1,218	1,789	1,282	1,761	-123	1,353	1,340	1,363	1,397	1,421	5,521
Cost of Revenue	917	916	910	928	920	939	947	1,066	1,095	1,087	1,093	1,132	1,150	1,183	1,176	1,200	999	1,098	1,161	1,293	1,291	1,211	1,403	1,407	1,391	1,394	1,409	1,419	1,424	1,443	1,110	1,495	1,122	1,524	37	1,173	1,184	1,216	1,287	1,246	4,933
Gross Profit	181	138	136	183	200	158	168	187	201	180	171	193	211	210	199	214	233	326	300	253	273	323	157	193	194	174	173	246	251	223	109	294	160	237	-159	181	155	147	110	175	588
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	26	27	26	28	28	27	31	32	29	30	30	29	31	34	34	34	33	36	35	35	36	38	38	38	37	39	39	42	43	41	44	48	50	47	80	33	36	40	46	39	161
Total Operating Expenses	62	64	63	71	67	66	71	79	81	81	83	81	86	87	87	86	114	170	136	51	-11	173	80	89	73	83	86	95	92	93	44	100	86	96	65	68	69	74	46	77	266
Operating Income	101	56	56	92	116	72	76	109	121	100	88	112	125	123	112	129	120	156	163	202	284	150	78	104	121	91	87	151	159	130	64	194	74	141	-225	113	87	73	64	98	322
Interest Expense	44	44	42	41	38	38	39	47	50	51	51	51	51	54	44	46	37	34	36	34	34	34	34	36	41	45	47	49	49	50	51	51	37	55	15	29	30	30	29	28	116
Pre-Tax Income	74	5.1	24	37	84	39	43	56	82	57	41	72	81	57	55	92	91	136	137	182	262	128	58	74	86	54	46	111	121	77	35	154	56	108	-214	96	70	56	50	82	259
Income Tax Expense	33	1.1	3.9	13	32	14	-78	12	21	14	11	18	21	13	12	22	23	32	35	45	66	28	-8.6	18	20	16	8.6	26	29	16	4.6	36	18	27	-51	21	12	12	13	18	55
Net Income	33	6.3	20	15	41	18	98	33	45	32	25	39	43	30	32	53	52	77	77	111	165	77	50	49	55	27	28	71	78	48	46	97	78	56	-16	57	41	29	20	44	134
EBITDA	137	93	93	134	154	111	120	158	184	158	141	164	180	176	152	190	117	207	179	266	347	199	143	160	178	151	146	212	220	179	111	258	138	213	-183	160	135	120	115	148	518

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings